rs5742913

This is a protein-altering variant in the TCF7 gene.

GWAS Catalog Trait Associations (3)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

eosinophil count

Vuckovic D et al. The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell 182(5):1214-1231.e11 (2020)
Allele A
OR 0.03
p 9.0e-19
N 408,112
Large GWAS
European
Allele A
OR 0.03
p 2.0e-17
N 474,237
Large GWAS
European
Allele A
OR 0.02
p 2.0e-12
N 394,642
Large GWAS
European
Allele A
OR 0.03
p 8.0e-9
N 365,954
Large GWAS
European

eosinophil percentage of leukocytes

Vuckovic D et al. The Polygenic and Monogenic Basis of Blood Traits and Diseases. Cell 182(5):1214-1231.e11 (2020)
Allele A
OR 0.03
p 2.0e-16
N 408,112
Large GWAS
European
Allele A
OR 0.02
p 2.0e-14
N 394,642
Large GWAS
European

asthma

Allele A
OR 1.06
p 3.0e-10
N 757,083
Large GWAS
European

About TCF7

This gene encodes a member of the T-cell factor/lymphoid enhancer-binding factor family of high mobility group (HMG) box transcriptional activators. This gene is expressed predominantly in T-cells and plays a critical role in natural killer cell and innate lymphoid cell development. The encoded protein forms a complex with beta-catenin and activates transcription through a Wnt/beta-catenin signaling pathway. Mice with a knockout of this gene are viable and fertile, but display a block in T-lymphocyte differentiation. Alternative splicing results in multiple transcript variants. Naturally-occurring isoforms lacking the N-terminal beta-catenin interaction domain may act as dominant negative regulators of Wnt signaling. [provided by RefSeq, Oct 2016]

View all TCF7 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…